EE175 Cost Effectiveness of Empagliflozin vs. Ertugliflozin in Patients with Type-2 Diabetes

Abstract

Authors

P Supner T Park

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×